If dioxin and ionizing radiation cause cancer, then it stands to reason that less exposure to them should improve public health. If mercury, lead and PCBs impair intellectual development, then less should be more. But a growing body of data suggests that environmental contaminants may not always be poisonous--they may actually be good for you at low levels.
Called hormesis, this phenomenon appears to be primarily an adaptive response to stress, says toxicologist Edward J. Calabrese of the University of Massachusetts at Amherst. The stress triggers cellular repair and maintenance systems. A modest amount of overcompensation then produces the low-dose effect, which is often beneficial.
This idea may sound bizarre, but such adaptation to stress is common, says physiologist Suresh Rattan of ¿rhus University in Denmark. Exercise, for instance, plays biochemical havoc with the body: starving some cells of oxygen and glucose, flooding others with oxidants, and depressing immune functions. "At first glance, there is nothing good for the body about exercise," he notes. But even couch potatoes know that moderate exercise is worthwhile. Rattan says that the cellular insults from exercise prompt the defense system to work more efficiently.
Over the past decade, Calabrese has compiled thousands of examples of hormesis from published scientific literature. Many findings challenge and even flout established theories about what is harmful. For example, the prevailing theory is that any increase in radiation exposure increases the risk of cancer. But biologist Ronald Mitchel of Atomic Energy of Canada has shown that a single low dose of ionizing radiation stimulates DNA repair, delaying the onset of cancer in mice; high doses produced the opposite effect, as expected. Prolonged exposure to extreme temperatures is also harmful, but Rattan has found that heating up human skin cells to 41 degrees Celsius (106 degrees Fahrenheit) twice a week for an hour slows aging in the cells.
Even well-established environmental headaches display some hormesis. The definitive rat study that linked high doses of dioxin to cancer, published in 1978 by Richard Kociba of Dow Chemical and his colleagues, also found that low doses reduced the incidence of tumors.
"Adaptation to such stresses is absolutely essential," Mitchel remarks. "If we couldn't adapt to changes in our environment, we would die." Such adaptation at the molecular level is seen in most primitive forms of life and has been evolutionarily conserved all the way up to humans, he adds.
Hormesis challenges the existing hazard-assessment process underlying environmental regulations, Calabrese says. Toxicologists usually determine the relation between exposure to contaminants and health risks by conducting animal experiments. They start out by giving lab animals a high dose that produces clear adverse effects. Then they work downward until they can estimate a concentration that doesn't cause harmful effects. For chemicals that don't cause cancer, they obtain a safe dose for humans by applying uncertainty factors to account for differences between mice and men and among individual people. The resulting safe dose for humans is then usually deemed to be about 0.01 to 0.001 the safe dose for mice. For carcinogens, toxicologists assume that exposure to any amount increases the risk.
But Calabrese suspects that in many cases, the benefits of hormesis may occur at levels higher than the recommended safe doses for humans. Thus, it might be possible to refine pollution standards so that we can reap the benefits of hormesis while still being protected against adverse effects in the environment. Or at the very least, it might be reasonable to stop worrying about exceedingly low exposures.
Researchers investigating adaptive stress responses aren't the only ones interested in effects at low doses. Scientists studying endocrine disruption are also joining in. They are concerned that contaminants that mimic hormones can have significant harmful effects at very low doses if exposure occurs during a susceptible developmental window. In some sense, endocrine disruption appears to be the opposite of hormesis, in which low doses could have unsuspected harmful effects because of the contaminant's chemical similarity to hormones.�
Advances in molecular biology are giving toxicologists the tools to investigate low-dose phenomena, according to Joseph V. Rodricks, health sciences director at Environ, environmental consultants in Arlington, Va. Instead of monitoring the onset of disease or cancer, toxicologists are beginning to use modern molecular biology tools to identify the critical early precursors to illness. They then monitor how the precursors vary at low doses.
Hormesis has much to prove if it is to revolutionize toxicology, Rodricks notes. Many of the hormetic dose-response relations that Calabrese has compiled raise more questions than answers, he says. For example, the dioxin study looks like hormesis if all types of cancer are combined, but hormesis doesn't show for individual types of cancer. Despite such skepticism, Rodricks is one of many toxicologists calling for a National Research Council review of this phenomenon.
Rebecca Renner writes about environmental issues from Williamsport, Pa.